News Archive

• Avid Bioservices Earns Committed Badge from EcoVadis for Sustainability Performance

  May 23, 2024

  TUSTIN, Calif., May 23, 2024 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ: CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing […]

  Read more

• Avid Bioservices to Participate in RBC Capital Markets Virtual CDMO Conference

  September 26, 2023

  TUSTIN, Calif., Sept. 26, 2023 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services […]

  Read more

• Avid Bioservices to Participate in RBC Capital Markets Global Healthcare Conference

  May 10, 2023

  TUSTIN, Calif., May 10, 2023 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services […]

  Read more

• Avid Bioservices Unveils Completed Mammalian Cell Facilities Expansion Providing Significantly Increased Capacity for Existing and Future Customers

  April 4, 2023

  Company to Host Open House to Celebrate Official Launch of Newest CGMP Mammalian Cell Manufacturing Suites within Myford Facility First Customer Project in Newly Expanded Capacity to Kick-Off This Month Company […]

  Read more

• Avid Bioservices to Participate in the Credit Suisse 31st Annual Healthcare Conference

  November 2, 2022

  TUSTIN, Calif., Nov. 02, 2022 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services […]

  Read more

• Avid Bioservices to Participate in RBC Global CDMO Conference

  September 27, 2022

  TUSTIN, Calif., Sept. 27, 2022 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services […]

  Read more

• Avid Bioservices Appoints Michael Alston, Jr. as Vice President, Operations

  September 22, 2022

  Accomplished Operations Professional Promoted from Role as Director of Project Engineering; Credited with Leading All of the Company’s Ongoing Facility Expansion Projects TUSTIN, Calif., Sept. 22, 2022 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ:CDMO), […]

  Read more

• Avid Bioservices to Participate in Morgan Stanley 20th Annual Global Healthcare Conference

  September 7, 2022

  TUSTIN, Calif., Sept. 07, 2022 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services […]

  Read more

• Avid Bioservices Appoints Pramthesh (Prem) Patel, Ph.D., as Vice President, Process Development for Mammalian Cell Business

  September 1, 2022

  Biopharmaceutical Executive with More than 30 Years of Experience With Top Global Big Pharma Companies GSK and Bristol Myers Squibb TUSTIN, Calif., Sept. 01, 2022 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated […]

  Read more

• Avid Bioservices Announces Further Expansion of Process Development Capacity for Mammalian Cell Business

  June 13, 2022

  New Laboratories Have Potential to Support an Additional $20 Million in Annual Process Development Revenue, Doubling Current Mammalian Cell Process Development Capacity Expansion to Cost Approximately $6 Million with Completion Anticipated by End of […]

  Read more


< View Latest News